Restoration® Modular Revision Hip System Post Market Study
Completed · Not applicable
Conditions studied: Arthroplasty, Replacement, Hip
In brief
The purpose of this study is to demonstrate survivorship of the femoral stem at 5 years.
Key facts
- Study ID
- NCT00962013
- Run by
- Stryker Orthopaedics
- People needed
- 137
- Starts
- 2004-01-01
- Expected to finish
- 2011-12-01
- Last updated by the study team
- 2017-03-29
Who can join
Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Candidates for cementless revision of a failed femoral prosthesis.
- Patients willing to sign the informed consent.
- Patients able to comply with follow-up requirements including post-operative weightbearing restrictions and self-evaluations.
- Male and non-pregnant female patients ages 18 to 85 years of age at the time of surgery.
You may not qualify if…
- Patients with ongoing infection.
- Patients who are severely immunocompromised.
- Patients who are prisoners.
Where it is running
- Orthopaedic Specialty Institute — Orange, California, United States
- Iowa Orthopaedic Center — Des Moines, Iowa, United States
- Kansas Joint and Spine Institute — Wichita, Kansas, United States
- Jewish Hospital Center for Advanced Medicine — Louisville, Kentucky, United States
- New West Sports Medicine and Orthopaedic Surgery — Kearney, Nebraska, United States
- Hospital for Joint Diseases — New York, New York, United States
- Beth Israel Medical Center — New York, New York, United States
- Crystal Clinic — Akron, Ohio, United States
- Providence Portland Medical Center — Portland, Oregon, United States
- Rothman Institute — Philadelphia, Pennsylvania, United States
- Orthopedic Associates of Corpus Christi — Corpus Christi, Texas, United States
- Scott and White Hospital — Temple, Texas, United States
- Providence Orthopaedic Specialities — Spokane, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.